欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/0370/003
药品名称VALSARTAN/HYDROCHLOROTHIAZIDE KRKA 160 MG/25 MG
活性成分
    • hydrochlorothiazide 12.5 mg
    • valsartan 80.0 mg
剂型Tablet
上市许可持有人Krka, d.d., Novo mesto Slovenia jana.trojanova@krka.biz
参考成员国 - 产品名称Czechia (CZ)
sukls22586/2015
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
      Valsartan/Hydrochloorthiazide Krka 160 mg/25 mg, filmomhulde tabletten
    • France (FR)
    • Poland (PL)
      Valsartan + hydrochlorothiazide Krka
    • Lithuania (LT)
      Valsartan/hydrochlorothiazide Krka 160 mg/25 mg plėvele dengtos tabletės
    • Estonia (EE)
      VALSARTAN/HYDROCHLOROTHIAZIDE KRKA
    • Hungary (HU)
      VALSARTAN/HYDROCHLOROTHIAZIDE KRKA 160 mg/25 mg filmtabletta
    • Bulgaria (BG)
      valsartan/hydrochlorothiazide KRKA
    • Romania (RO)
      Co-Valsacor 160 mg/ 25 mg comprimate filmate
    • Slovakia (SK)
      Valsartan/hydrochlorotiazid Krka 160 mg/25 mg filmom obalené tablety
    • Slovenia (SI)
      Valsartan/hidroklorotiazid Krka 160 mg/25 mg filmsko obložene tablete
许可日期2010/11/15
最近更新日期2023/11/20
药物ATC编码
    • C09DA03 valsartan and diuretics
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase